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Childhood obstructive sleep apnea (OSA) syndrome is an increasingly recognized morbidity affecting 
2-5% of children specifically Asian Indian children due to growing urbanization and nutrition 
transition, obesity and metabolic syndrome. It is associated with metabolic (resistance to insulin-
mediated glucose uptake; insulin resistance), cardiovascular (hypertension and cardiac arrhythmias) 
and neuropsychological disorders. Polysomnography is the gold standard technique for diagnosis of 
OSA in children. Severity of OSA is assessed by calculating apnea/hypopnea index. Apnea in children 
is defined as absence of airflow with continued chest wall and abdominal wall movement for duration 
longer than two breaths. In children, the most common cause of OSA is enlarged tonsils and 
adenoids. During sleep there is a considerable decrease in muscle tone, which affects the airway and 
breathing. Some other causes of OSA in children include obesity, tumor, Down syndrome, pierre-
robin syndrome, cleft palate repairs, receding chin, allergies and anatomical abnormalities.  Wide 
variety of intermediate phenotype and genes are involved in sleep apnea which makes this syndrome 
genetically complex. Various adipokines and cytokines have a key role in OSA. Some studies have 
suggested that oxidative stress may also contribute to the development of OSA. Treatment of patients 
with OSA has typically been focused on the management of associated conditions such as obesity, 
adenotonsillectomy, hyperlipemia and cardiovascular disease. Different modalities of treatment 
include weight loss, lifestyle modifications and, continuous positive airway pressure therapy and 
surgical treatment.   
 






Polysomnography (PSG) is the physiologic recording of 
variables such as  brain  waves, eye  movement, muscle  
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tone, breathing and heart rhythm during sleep. Over 80 
different types of sleep disorders have been identified, 
with obstructive sleep apnea (OSA) symptoms occurring 
in one out of every 20 people. Polysomnography is used 
to diagnose, or rule out, many types of sleep 
disorders including narcolepsy, idiopathic hypersomnia, 
periodic limb movement disorder,  parasomnias, 
and sleep apnea. 
The Greek word “apnea” literally means “without 
breath.” There are three types of apneas: obstructive, 
central, and mixed; of the three, obstructive is the most 
commonest (Guilleminault et al., 1976). Despite the 
difference in the root cause of each type, in all three, 
subjects with untreated sleep apnea stop breathing 
repeatedly during their sleep, sometime hundreds of 
times during the night and often for a minute or longer 






Obstructive sleep apnea (OSA) is a common disorder 
associated with cardiovascular and neuro-psychological 
disorders (Redline and Young, 1993). OSA has been 
estimated to affect 3%–7% of adult men, 2%–5% of 
adult women, (Feng and Chen, 2009; Young et al., 2002; 
Lumeng and Chervin, 2008) and up to 4% of children 
(Lumeng and Chervin, 2008; Feng et al., 2012). 
Although data are sparse, frequency for OSA has been 
estimated to be 6%-8% in adult population of India 
(Sharma et al., 2004).  
Obesity is a significant risk factor for OSA.  The 
prevalence of childhood obesity has tripled since the 
early 1980s, and is presently estimated to be 16%. The 
risk of OSA in obese children is high at 36%, and may 
exceed 60% if habitual snoring is present. In a previous 
multi-centeric study, Bhattacharjee et al. (2010) included 
500 subjects, half of whom were obese, 
adenotonsillectomy led to improved clinical symptoms.. 
Chen et al. (2012) conducted a prospective study of 
prepubertal children treated with adenotonsillectomy with 
subsequent normal polysomnography testing. Most 
obese children with OSA will also have adenotonsillar 
hypertrophy. In recent years, “metabolic syndrome” has 
been shown to be an important manifestation of obesity 
in children. It encompasses a cluster of metabolic and 
cardiovascular abnormalities such as dyslipidemia, 
hypertension, insulin resistant, type 2 diabetes mellitus 
(T2DM) and inflammatory states may play an 
independent role in the pathophysiology of obstructive 
sleep apnea syndrome (OSAS) in children (Redline et 
al., 1999). Studies on various aspects of OSA in children 
are limited. Adult studies are used to explain various 





International scenario  
 
Studies on children and adolescents have shown that 
the prevalence of sleep-disordered breathing (SDB) was 
about 2% among normal children (Lumeng and Chervin, 
2008; Rosen et al., 2003) and about 2.5–6% among 
adolescents (table 1). Guilleminault et al. (1981) 
reported that 10% of children diagnosed with OSAS 
were obese. Marcus et al. (1998) showed that 46% of 
unselected obese children undergoing polysomnography 
had OSAS. Similarly, Kalra et al. (2005) reported that 
55% of morbidly obese children undergoing bariatric 
surgery had evidence of OSAS. 
A population-based study (Kalra et al., 2005) 
involving 399 children between 2 and 18 years of age 
found that obesity was the most significant risk factor for 
OSAS. The reason for such a high prevalence of OSAS            
in obese children compared with the 2% reported  in  the  




general population remains unknown. However, it may 
be related to a different underlying phenotype 
distinguishing it from OSAS in non-obese children and 
an augmented effect on known causative factors 
resulting from the obese phenotype. Although the 
prevalence of OSAS in obese children seems to be very 
high, the true prevalence of this disease in the general 
obese population cannot be ascertained from the above 
studies, which were performed on small and selected 
obese populations. The diagnostic criteria for OSA in 
children are somewhat different from those in adults. 
The apnoea–hypopnoea index (AHI) is an index of sleep 
apnea severity that combines apneas and hypopneas. 
AHI is the number of apneas and hypopneas per 
hour. AHI values are typically categorized as 5–15/hr = 
mild; 15–30/hr = moderate; and > 30/h = severe. Among 
children, an apnea–hypopnea index (AHI>1) and oxygen 
desaturation ≥ 4% are indicators of mild OSA [17]. In 
comparison, an AHI of 5 (or sometimes 10) among 





According to preliminary reports, OSA affects 3-8% 
adults in urban population in India (Sharma et al., 2006). 
As observed in various studies, with growing 
urbanization and nutrition transition, obesity is increasing 
in Asian Indians (Misra et al., 2005), which can be a risk 
factor for OSA in Asian Indians as well. Although these 
diseases are multi-factorial, genetic associations and 
hormonal determinants have been suspected and need 
to be researched in Asian Indians. It is important to 
investigate these issues in view of large burden of the 
metabolic syndrome and coronary heart disease in Asian 
Indian in India and those settled as sizable migrant 
populations in several countries worldwide. As observed 
in various studies, with growing urbanization and 
nutrition transition, obesity, OSA and metabolic 
syndrome is increasing in Asian Indians (Misra et al., 
2005; Agrawal et al., 2011).  
Nanaware et al. (2006) studied 56 children’s  in the 
study 23(41%) cases were positive for SDB, 12 (52.1 %) 
patients had craniofacial abnormalities, 4 (17.3%) had 
neuromuscular and skeletal disorders, 2 (8.6%) had 
adenotonsillar hypertrophy, 1(4.3%) had bilateral vocal 
cord palsy and 3 (13%) had sleep apnoea associated 
with multisystemic disorders. Further, he showed that 
41% of suspected cases were detected to have SDB. 
Jain and Sahni (2002) studied 40 children (age group 4-
12 years) with adenoidectomy and tonsillectomy was 
subjected to pre and post-operative polysomnography. 
They observed that 75% children presented with 
predominant obstructive symptoms and 73.3%         
were found to have OSA. There was a  highly  significant  
 




Table 1. Prevalence of sleep apnea in children 
 
 
improvement in polysomnographic scores following 





The most common cause of OSA is enlarged tonsils and 
adenoids. During sleep there is a considerable decrease 
in muscle tone, which affects the airway and breathing. 
Infections may cause these glands to enlarge. Large 
adenoids may completely block the nasal passages and 
make breathing through the nose difficult. Many of 
children have little difficulty breathing when awake; 
however, with decreased muscle tone during sleep, the 
airway becomes smaller, and the tonsils and adenoids 
block the airway, making the flow of air more difficult and 
the work of breathing harder. Obesity may cause 
obstructive sleep apnea. Some other of the causes of 
OSA in children include down syndrome, pierre-robin 
syndrome, cleft palate or cleft palate repairs, receding 
chin, allergies, anatomical abnormalities (Redline et al., 
1999; Rosen et al., 2003; Nanaware et al., 2006; Jain 





The etiology of childhood OSA is quite different from that 
of the adult condition. The upper airway resistance 
syndrome is characterized by brief, repetitive respiratory 
effort–related arousals during sleep in the absence of 
overt apnea, hypoapnea and gas exchange 
abnormalities (Guilleminault et al., 1993). Also, children 
with OSA manifest recurrent  episodes  of  partial  airway 
obstruction. During non-rapid eye movement (NREM) 
sleep, obstructive events are generally accompanied by 
an initial decrease in respiratory effort, followed by a 
graded increase. In REM sleep, the respiratory effort is 
more variable and may increase or decrease during an 
obstruction. In addition to adenotonsillar hypertrophy, 
causes of airway narrowing include allergic rhinitis, 
turbinate hypertrophy, deviated septum, and maxillary 
constriction (Guilleminault and Abad, 2004). Figure 1. 
 
 
OSA and hypertension  
 
The effect of simple snoring on blood pressure (BP) was 
examined in a study that included children with snoring 
but without OSA. Kohyama et al. (2003) showed that 
those with apnea hypoapnea index (AHI) >10 had higher 
systolic and diastolic BP indexes during REM sleep and 
during wakefulness compared with those with AHI <10. 
Another study found that hypertension in 239 Hispanic 
children from the Tucson Children (Kohyama  et al., 
2003). Systolic and diastolic hypertension and sleep 
efficiency were independently associated with 
respiratory disturbance index. Night time BP may be 
higher in children with OSA. BP recorded during 
polysomnography in 41 children with OSA subjects and 
26 children with primary snoring showed a significantly 
higher diastolic BP for sleep and wakefulness in the 
OSA group (Marcus et al., 2006). On the basis of the 
current literature, there is no definitive evidence that 
established hypertension is a common cardiovascular 
complication of OSA in children and adolescents.  It is 
unlikely that mild OSA in children will lead to significant 
cardiac dysfunction in the pediatric  age range. However,  
No. of subjects    Location Year Age Definition of apnea Prevalence (%) 
10,279 Singapore 2004 4–7 yr Child stops breathing for short periods  during sleep (yes/no) 1.2 
5,979  China 2005 2–12 yr Breathing pauses 0.2 
3,871 Korea 2003 15–18 yr Breathing cessation during sleep >43/wk 0.9 
3,680 Greece 2004 1–18 yr Child stops breathing during sleep every 1.0 
3,047 Hong Kong 2005 6–12 yr Child stops breathing for a few seconds or  struggles to 
breathe 
1.5 
3,045 Belgium 2006 6–13 yr Child gasps for breath or is unable to breathe  during sleep 0.8 
2,900 Iran 2006 11–17 yr Apnea (unclear how defined) 0.4 
2,147 Turkey 2004 5–13 yr Apnea (unclear how defined) 5.6 
1,494 United States 2003 4–11 yr Child stops or struggles to breathe, child’s lips turned blue, 3.8 
1,014 United States 2000 13–16 yr Child stops breathing or breathes abnormally every 0.4 
895 Italy 2001 3–11 yr Child has apnea during sleep 2.8 
454 Iceland 1995 6 mo–6 yr Apnea often and very often 1.6 
325 Sweden 1995 4 yr Apnea every night 1.5 
245 United Kingdom 1996 0–10 yr Child appears to hold breath for short periods of time during  
sleep sometimes or often 
4.0 
101  Spain 2001 12-16 yr Witnessed apnea ever 2.9 
 





Figure 1. Pathophysiology of OSA 
 
 
it is not known whether mild OSA during early childhood 
predisposes to vascular injury or BP dysregulation 
during adolescence and adulthood. Whether OSA is an 
independent risk factor for systemic hypertension in 
children remains unanswered. 
 
 
Relation between OSA, fat distribution and insulin 
resistance 
 
There is no consistent relationship between pediatric 
OSA and measures of body fat distribution (Verhulst et 
al., 2007). Although imaging studies specific to obese 
children have not been performed, adult studies 
indicated that increased deposition of fat in the 
parapharyngeal fat pads near and within the soft palate 
contributes to airway obstruction. Obese subjects also 
have lower lung volumes, increasing both airway 
compliance and gas exchange abnormalities.  Previous 
study (Verhulst et al., 2009) showed that the relationship 
between fat distribution and OSA relied on 
measurements of waist/hip ratios and total body fat and 
has not found a clear cut relationship between fat 
distribution and OSA. In children, both visceral adiposity 
and intramyocellular lipid content, a measure of fat 
accumulation at the cellular level determined by 
spectroscopy, has been shown to be a strong predictor 
of insulin resistance (Weiss et al., 2005).  
OSA is associated with insulin resistance, 
cardiovascular and neuropsychological disorders. It 
affects 4-11% of the white Caucasian population. 
Obesity appears to increase risk of OSA nearly 10–14-
folds, with the most marked effects observed in middle-
aged subjects (Guilleminault et al., 1976; Redline and 
Young, 1993). Obesity may increase susceptibility to 
OSA through fat deposition in upper airway tissues. The 
co-occurrence of OSA, central obesity, hypertension, 
and hyperglycaemia suggests that OSA is a part of the 
metabolic syndrome in adult subjects (Catterall et al., 
1984). Despite some evidence, relationship of OSA with 
insulin resistance independent of obesity remains to be 
established. In our ongoing investigation on metabolic 
and genetic factors of OSA, nearly 2/3rd patients with 
the metabolic syndrome have OSA [unpublished 
observations]. Clearly, more investigations on the 
relationship between the metabolic syndrome and OSA 
are needed in South Asians. 
 
 
Genetics of OSA 
 
Many studies have been documented showing strong 
genetic association of OSA (Abdelnaby et al., 2011; 
Bharat et al., 2011; Khalyfa et al., 2012; Gozal et al., 
2012). The list of biologically plausible candidate genes 
that might be involved in the determination of OSA and 
associated traits is extensive and growing. There are two 
kind of approaches used to study genetic association of 
a disease: whole genome scan analysis and candidate 
gene approach. Mapping  of  human  susceptible  loci for  
 




OSA is difficult due to high population frequency and 
genetic heterogeneity. Some studies carried out using 
candidate gene approach have also been documented 
but no specific conclusion can be drawn from those 
studies.  
Abdelnaby et al. (2011) reported that the presence 
of symptoms of excessive daytime sleepiness to 
increased tumor necrosis factor (TNF-α) levels and the 
TNF-α −308G gene polymorphism. Bhushan et al. 
(2011) showed that young school-age children with OSA 
and obesity exhibit higher circulating levels of the pro-
inflammatory fatty acid binding protein (FABP)-4. 
Furthermore, selective variants in FABP4 gene appear 
to contribute to the proinflammatory or diabetogenic 
potential of OSA and obesity during childhood. Khalyfa  
et al. (2012) was studied a total of 614 consecutive 
children ages 5-8 years. He showed that childhood OSA 
was associated with higher plasma macrophage 
migration inhibitory factor (MIF), high-sensitivity C-
reactive protein (Hs CRP), and fasting insulin levels that 
promote cardiometabolic risk, and the MIF gene SNP 
rs10433310 may be risk factor for OSA. Gozal et al. 
(2012) reported that the Nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase gene may 
account for important components of the variance in 
cognitive function deficits associated with OSA in 
children. Further studies replicating these findings in 
different populations are needed as are studies involving 
fine mapping of this region. In Asian Indian, till date no 




Hormonal studies in OSA 
 
Most of the documented hormonal studies have been 
carried out mainly taking acromegaly as an intermediate 
in OSA. Hormonal levels also have been found to be 
strongly associated with sleep. Disturbed sleep wake 
behavior by sleep deprivation results in changes in 
hormone secretion. Studies carried out individually in 
OSA have been done in small number of subjects 
(Meyer et al., 2012; O'donnell et al., 1999) but no study 





Treatment of patients with OSA has typically been 
focused on the management of associated conditions 
such as obesity, Adenotonsillectomy, hyperlipemia and 
cardiovascular disease (Capdevila et al., 2008). Weight 
loss has been shown to improve insulin sensitivity, and 
OSA may resolve with weight reduction. Insulin 





many cases of OSA. Different modalitie of treatment 
have been advocated for the management of OSA. 
These include lifestyle modifications and weight 





Adenotonsillectomy (T & A) is generally considered to be 
the standard treatment of childhood OSA with normal 
craniofacial features and uncomplicated medical status. 
In a meta-analysis of the published literature, the 
success rate in the context of OSA was observed to be 
approximately 85% (Lipton and Gozal, 2003). This data 
may actually be lower, particularly among obese children 
with OSA or among children with severe OSA (Shine et 
al., 2006). However, another study has suggested that 
cure is achieved in less than 50% with persistent SDB 
occurring because of other facial structural issues such 
as retrognathia, enlarged nasal turbinates and a 
deviated septum. A study from India, Paramasivan 
(2012) studied 50 cases of children with OSA age group 
between 5 and 12 years were randomly selected for 
each group and studied. He concluded that the use of 
coblation for adenotonsillectomy may have several 
advantages over standard methods for the treatment of 
children with OSA. It is highly efficacious, practical and 
safe with less morbidity and less complications. 
 
 
Life style modifications and weight reduction 
 
Weight gain is a significant risk factor for the 
development of OSA. In the vast majority of OSA cases 
the illness can be improved, if not eliminated, with 
significant weight loss. However anatomic abnormalities 
may cause the condition to persist. The amount of 
weight a patient needs to lose to achieve these benefits 
varies. Some may need only a modest reduction in 
weight to gain improvement, while others may require 
significant weight loss. It is usually not necessary to slim 
down to an "ideal body weight" to achieve these 
benefits. The theoretical advantages of weight loss 
include decreasing insulin resistance and, if combined 
with exercise, increasing muscle insulin sensitivity. 
Weight reduction has been clearly associated with 
improvement in liver biochemical tests. One study 
indicated that in obese children, weight loss and 
maintaining a healthy diet might prove to be the ultimate 
treatment for their OSA (Benninger and Walner, 2007). A 
recent study in adolescents showed that 72 percent (13 
out of 21) overweight children with sleep disorder 
breathing were able to reduce their AHI to <2 with weight 







Continuous positive airway pressure therapy (CPAP) 
 
CPAP is an effective therapy for OSA. It is useful for 
children who are unable to have T&A or who have 
residual SDB  post operatively. The CPAP machine 
sends air under pressure through the tube into the mask, 
where it imparts positive pressure to the upper airways. 
This essentially acts as "splints" and keeps the upper 
airways open and prevents them from collapsing. CPAP 
is the most commonly prescribed treatment for OSA. 
The advantages of CPAP are that it is safe and 
completely reversible and in generally quite well 
tolerated. Ghoshal et al. (2010) showed that the 
treatment with CPAP was effective in 68.23% cases in 
first attempt. More than half of the cases (62.42%) 
required 10 cm of H20 or less CPAP. Another study 
indicated that CPAP has been found to be effective for 






Obesity is associated with OSA in children.  Importantly, 
several epidemiologic studies have demonstrated that 
sleep related disorders are an independent risk factor for 
obesity and hypertension, probably resulting from a 
combination of intermittent hypoxia and hypercapnia, 
arousals, increased sympathetic activity, and altered 
baroreflex control during sleep.   
Obesity and MS are increasing in Asian Indians. 
Although these diseases are multifactorial, genetic 
associations and hormonal determinants have been 
suspected but not researched. It is important to 
investigate these issues in view of large burden of insulin 
resistance and metabolic syndrome in Asian Indian 
chidern. We feel that strongly support a relationship 
between OSA. Further studies are needed to elucidate 
the precise nature of this relationship.   
The genetic and hormonal determinants of OSA 
have received little attention. Wide variety of 
intermediate phenotype and genes are involved in sleep 
apnea which makes this syndrome genetically complex. 
In a linkage analysis study, genes associated with 
obesity were shown to be relevant for further study of 
OSA.  
Lifestyle intervention should be first line treatment 
for OSA patients. In identifying and treating OSA among 
children with adenotonsillar hypertrophy, dentists can 
play an important role by noting the size of the tonsils 
when looking into child's mouth and informing the child's 
parents and the primary care physician when enlarged 
tonsils are observed. There is currently no well 
established treatment for patient with OSA. 
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